PAA 5.00% 10.5¢ pharmaust limited

Does this draft make sense to professionals?New discovery by...

  1. 286 Posts.
    lightbulb Created with Sketch. 13

    Does this draft make sense to professionals?

    New discovery by scientist's is troubling...

    Will K9 Cancer research using Monepantel overcome the hibernation of cancer cells issue?

    Pharmaust ltd PAA ASX last year delivered the K9 Lymphoma Phase I and II Trials Data Dossier to VM, Pharmaust claimed they were in the enviable position to have a Manufacturing and Distribution agreement penned with a Fortune 500 ,Global Vetrinary Distributor.

    They confirmed the previously announced data that Monepantel eliminates 95% of Cov 19 Virus Cells in 72 hours.

    The Trials have been confirmed in conjunction with the asture and well respected WEHI Walter & Eliza Hall Institute with a High Degree of Oversight due to significant Govt funding.

    Pharmaust being the consummate proffesionals that they are will now move on swiftly to carry out necessary trials to enable the Treatment to be administered to Human Patients that have regretably contacted the Cov19 Virus.

    The Company may now call upon all of its resources to accelerate the timely commercialisation of a Safe in home treatment for Cov 19 and Variant mutations that fall with in the SARs and SARs-2 Virus Family.

    #chemotherapy#breatcancer#prostratecancer
    #health #cancer #oncology

    https://bigthink.com/surprising-science/cancer-cells-hibernate-chemotherapy

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.005(5.00%)
Mkt cap ! $33.25M
Open High Low Value Volume
10.5¢ 10.5¢ 9.9¢ $69.37K 686.4K

Buyers (Bids)

No. Vol. Price($)
2 55120 9.9¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 317049 3
View Market Depth
Last trade - 15.56pm 26/01/2021 (20 minute delay) ?
(live)
Last
10.0¢
  Change
0.005 ( 0.00 %)
Open High Low Volume
10.0¢ 10.5¢ 10.0¢ 173103
Last updated 15.56pm 26/01/2021 (live) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.